Medicare Enrolled

Dr. Dariusz Nowak, M.D.

Internal Medicine · Linden, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
515 N WOOD AVE, Linden, NJ 07036
9089253300
In practice since 2006 (19 years)
NPI: 1740200666 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nowak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nowak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nowak

Dr. Dariusz Nowak is an internal medicine specialist in Linden, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Nowak performed 4,166 Medicare services across 1,627 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nowak received a total of $12,887 from 73 pharmaceutical and/or device companies across 722 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nowak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 7% volume in NJ $12,887 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,166
Medicare services
Top 7% in NJ for internal medicine
1,627
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~219 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,800 $18 $30
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
659 $101 $200
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
352 $28 $70
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
189 $95 $180
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
96 $69 $160
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
90 $8 $15
Continuous glucose monitoring, tissue fluid
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin.
87 $57 $100
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
87 $135 $280
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
78 $153 $728
Digital analysis of brain wave activity (EEG)
This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision.
78 $134 $515
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
68 $21 $30
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
65 $13 $40
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
63 $44 $150
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes 62 $239 $334
ECG, 1-3 leads with physician review
A simple electrocardiogram recording using one to three leads. A physician reviews the results.
61 $6 $35
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
61 $109 $266
Continuous glucose monitoring, sensor under skin
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment.
54 $134 $250
Blood glucose level test
A test that measures the amount of sugar in your blood.
51 $4 $10
Electrocardiogram, 1-3 leads with physician review
A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician.
28 $8 $35
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
23 $1 $25
Autonomic nervous system testing with heart rate response to deep breathing
This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing.
20 $39 $380
Autonomic nervous system function test
This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure.
20 $42 $400
Online digital evaluation for established patient, 5-10 minutes
This service involves an online digital evaluation and management visit for an established patient. It covers a total time of 5 to 10 minutes over a period of up to 7 days.
20 $13 $30
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
17 $103 $230
Ultrasound of arm and leg arteries
This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries.
14 $15 $360
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
12 $124 $200
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
11 $73 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,887
Total received (2018-2024)
Avg $1,841/year across 7 years
Top 6% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
722
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,064 (85.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,823 (14.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,306
2023
$1,857
2022
$3,127
2021
$1,516
2020
$2,404
2019
$1,220
2018
$1,457

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$249
Amneal Pharmaceuticals LLC
$216
Novo Nordisk Inc
$170
Dexcom, Inc.
$122
SANOFI-AVENTIS U.S. LLC
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
AstraZeneca Pharmaceuticals LP
$47
Abbott Laboratories
$45
ABBVIE INC.
$44
Medtronic, Inc.
$35
Ascensia Diabetes Care Us Inc.
$31
Currax Pharmaceuticals LLC
$30
Radius Health, Inc.
$24
PFIZER INC.
$21
Echosens North America, Inc.
$19
Verity Pharmaceuticals Inc.
$19
Acella Pharmaceuticals, LLC
$18
Antares Pharma, Inc.
$18
GlaxoSmithKline, LLC.
$17
Amgen Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$16
IBSA Pharma Inc.
$15
Xeris Pharmaceuticals, Inc.
$14
Top 3 companies account for 48.6% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,805
Senseonics, Incorporated
$1,771
Novo Nordisk Inc
$1,371
AstraZeneca Pharmaceuticals LP
$1,308
SANOFI-AVENTIS U.S. LLC
$788
Dexcom, Inc.
$754
Amneal Pharmaceuticals LLC
$512
Boehringer Ingelheim Pharmaceuticals, Inc.
$445
Medtronic, Inc.
$381
Ascensia Diabetes Care Us Inc.
$271
Merck Sharp & Dohme Corporation
$264
Janssen Pharmaceuticals, Inc
$197
IBSA Pharma Inc.
$161
Abbott Laboratories
$157
Takeda Pharmaceuticals U.S.A., Inc.
$155
DEXCOM, INC.
$151
Medtronic MiniMed, Inc.
$134
Kowa Pharmaceuticals America, Inc.
$113
Currax Pharmaceuticals LLC
$112
GlaxoSmithKline, LLC.
$109
Amgen Inc.
$108
Shire North American Group Inc
$99
ABBVIE INC.
$89
Gemini Laboratories, LLC
$85
AbbVie Inc.
$82
Xeris Pharmaceuticals, Inc.
$73
Mannkind Corporation
$72
Valeritas, Inc.
$68
Insulet Corporation
$67
Antares Pharma, Inc.
$66
Eisai Inc.
$63
MannKind Corporation
$59
Supernus Pharmaceuticals, Inc.
$51
Amarin Pharma Inc.
$51
Becton, Dickinson and Company
$48
Corcept Therapeutics
$47
AbbVie, Inc.
$42
Allergan Inc.
$41
Radius Health, Inc.
$38
EISAI INC.
$38
Zealand Pharma US, Inc.
$36
PFIZER INC.
$35
Bigfoot Biomedical Inc
$33
CeQur Corporation
$32
Acerus Pharmaceuticals Corporation
$28
Endo Pharmaceuticals Inc.
$27
RECORDATI_RARE_DISEASES_INC.
$27
Nalpropion Pharmaceuticals LLC
$27
Bayer Healthcare Pharmaceuticals Inc.
$26
Aytu BioScience, Inc
$23
Echosens North America, Inc.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Verity Pharmaceuticals Inc.
$19
Acella Pharmaceuticals, LLC
$18
Azurity Pharmaceuticals, Inc.
$17
Orexigen Therapeutics, Inc.
$16
Astellas Pharma US Inc
$16
IDORSIA PHARMACEUTICALS US INC
$16
Genentech USA, Inc.
$15
Esperion Therapeutics, Inc.
$15
Althera Pharmaceuticals LLC
$15
Intuity Medical Inc
$15
VIVUS, Inc.
$14
Merck Sharp & Dohme LLC
$14
ARBOR PHARMACEUTICALS, INC.
$14
LIFESCAN, INC.
$14
Horizon Therapeutics plc
$14
West-Ward Pharmaceuticals
$14
Tolmar, Inc.
$14
Mallinckrodt Hospital Products Inc.
$13
Regeneron Healthcare Solutions, Inc.
$13
Alexion Pharmaceuticals, Inc.
$12
Clarus Therapeutics Inc.
$11
Top 3 companies account for 38.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFREZZA · ANORO ELLIPTA · AREXVY · AVEED · Adthyza · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BD ULTRA-FINE · BD Ultra-Fine · BYSTOLIC · Belviq · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Creon · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EMGALITY · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · EVERSENSE E3 SMART TRANSMITTER KIT · Edarbyclor · Eversense · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · LYRICA · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 670G System · Mitigare · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · Natesto · Omnipod · Otezla · Ozempic · PRALUENT ALIROCUMAB INJECTION · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · QULIPTA · QUVIVIQ · RECORLEV · Repatha · Roszet · Rybelsus · SHINGRIX · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TESTOPEL · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Trintellix · Tymlos · UBRELVY · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · VERQUVO · VIBERZI · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xofluza · ZEGALOGUE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for internal medicine in NJ.

Looking for an internal medicine specialist in Linden?
Compare internal medicine physicians in the Linden area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
9,514
Per 100K population
1661.7
County median income
$100,117
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
2.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nowak is a clinical cardiology specialist, with above-average Medicare volume (top 7% in NJ), with low-engagement industry engagement in the top 6% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nowak experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Nowak performed 1,800 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nowak receive payments from pharmaceutical companies?
Yes. Dr. Nowak received a total of $12,887 from 73 companies across 722 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nowak's costs compare to other internal medicine physicians in Linden?
Dr. Nowak's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nowak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →